<List><item><source>MED</source><extId>28587613</extId><pmcid>PMC5461628</pmcid><annotations><annotation><prefix>Trial registration </prefix><exact>NCT03046576</exact><postfix>, registered on 5 Feb</postfix><tags><tag><name>NCT03046576</name><uri>http://identifiers.org/clinicaltrials/NCT03046576</uri></tag></tags><id>http://europepmc.org/abstract/MED/28587613#europepmc-0d9765c8c6111bb0477340298338c0ad</id><type>Accession Numbers</type><section>Abstract (http://purl.org/dc/terms/abstract)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>trials (SAVOR TIMI, </prefix><exact>NCT01107886</exact><postfix>; EXAMINE, NCT009687</postfix><tags><tag><name>NCT01107886</name><uri>http://identifiers.org/clinicaltrials/NCT01107886</uri></tag></tags><id>http://europepmc.org/articles/PMC5461628#europepmc-7e9df8f83c7d01686aa739ba9ff75a4a</id><type>Accession Numbers</type><section>Discussion (http://purl.org/orb/Discussion)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>T01107886; EXAMINE, </prefix><exact>NCT00968708</exact><postfix>; and TECOS, NCT0079</postfix><tags><tag><name>NCT00968708</name><uri>http://identifiers.org/clinicaltrials/NCT00968708</uri></tag></tags><id>http://europepmc.org/articles/PMC5461628#europepmc-4f3f4fafdff8f1ba9891374a4c13918f</id><type>Accession Numbers</type><section>Discussion (http://purl.org/orb/Discussion)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>0968708; and TECOS, </prefix><exact>NCT00790205</exact><postfix>) demonstrated that </postfix><tags><tag><name>NCT00790205</name><uri>http://identifiers.org/clinicaltrials/NCT00790205</uri></tag></tags><id>http://europepmc.org/articles/PMC5461628#europepmc-f663b0b69955fcb4046cfde23e710cce</id><type>Accession Numbers</type><section>Discussion (http://purl.org/orb/Discussion)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation></annotations></item></List>